Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion

On Wednesday, US drug company Pfizer Inc (NYSE:PFE) sold its entire stake in Haleon Plc (NYSE:HLN) to institutional investors and the consumer healthcare firm at 385 pence per share ($5.00).

Under the deal, Haleon agreed to purchase approximately 44 million ordinary shares at 385 pence from Pfizer off-market for an aggregate consideration of approximately 170 million pounds, or $220 million.

Also Read: Pfizer’s Direct-To-Consumer Model Faces Scrutiny From US Senators 

Pfizer has sold approximately 618 million ordinary shares in Haleon to institutional investors at 385 pence per share, raising gross sale proceeds of approximately 2.4 billion pounds, or $3.1 billion.

After the off-market purchase and Pfizer’s offering to institutional investors, Pfizer’s interest ...